Understanding non-small cell lung cancer progression at all stages
Part of Cancer, Lungs & breathing clinical trials.
This study is looking at how non-small cell lung cancer (NSCLC) changes and progresses over time, from early to advanced stages. By studying people with all stages of the disease, researchers hope to learn more about what affects a person's prognosis and how the cancer evolves. This may help doctors better understand the cancer and develop better treatments.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are an adult (age 18 or older).
- You have been diagnosed with non-small cell lung cancer (NSCLC).
- Your cancer stage is between I and IV (any stage of NSCLC is welcome).
- You are being treated at Bordeaux University Hospital.
- You are covered by French social security (or are a beneficiary).
- You are willing to give your permission to be in the study (non-opposition).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how tumor and blood biomarker results can guide treatment for people with non-small cell lung cancer (NSCLC). Depending on the cancer stage, it may follow standard-of-care treatment plans around surgery or first-line immunotherapy.
This study looks at how lung cancer changes over time by analyzing tumor tissue and blood. It may help researchers understand what drives cancer relapse after early-stage surgery.
This study looks at how EGFR-mutated lung cancer changes over time and tries to find markers that can predict how well you might respond to treatment. You will provide a tumor sample for genetic analysis.
This trial does not test a new drug. It looks at existing medical records to compare how well different treatments work for people with advanced non-small cell lung cancer. You may be eligible if your cancer is advanced and you are not in another clinical trial.
This study collects blood and tissue samples from people with non-small cell lung cancer (NSCLC) either before or after treatment. It aims to help researchers learn more about how tumors respond, especially in cancers with specific genetic changes or after certain pre-surgery therapies.
This trial looks at aging-related changes in older adults (70+) with early-stage lung cancer who are planning to have surgery. The goal is to better understand how these changes might affect recovery and outcomes, which could help improve care for future patients.
Hear when a new Non Small Cell Lung Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.